Capsida Biotherapeutics Patents – Insights & Stats (Updated 2024)

Capsida Biotherapeutics has a total of 20 patents globally, out of which no patent have been granted. Of these 20 patents, more than 65% patents are active. Australia and Canada is where Capsida Biotherapeutics has filed the maximum number of patents, followed by Japan, United States of America and Europe. Parallelly, Canada seems to be the main focused R&D centre and also is the origin country of Capsida Biotherapeutics.

Capsida Biotherapeutics was founded in 2019. Capsida Biotherapeutics is a biotechnology company specializing in the development of precise gene therapies tailored for debilitating genetic disorders across central nervous system (CNS) and non-CNS conditions.

Do read about some of the most popular patents of Capsida Biotherapeutics which have been covered by us in this article and also you can find Capsida Biotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Capsida Biotherapeutics patent portfolio.

How many patents does Capsida Biotherapeutics have?

Capsida Biotherapeutics has a total of 20 patents globally. These patents belong to 13 unique patent families. Out of 20 patents, 13 patents are active.

How Many Patents did Capsida Biotherapeutics File Every Year?

Capsida Biotherapeutics patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCapsida Biotherapeutics Applications FiledCapsida Biotherapeutics Patents Granted
20236
20227
20217

How many Capsida Biotherapeutics patents are Alive/Dead?

Worldwide Patents

Capsida Biotherapeutics Patent Portfolio

How Many Patents did Capsida Biotherapeutics File in Different Countries?

Capsida Biotherapeutics Worldwide Patent Filing

Countries in which Capsida Biotherapeutics Filed Patents

CountryPatent
Australia2
Canada2
Japan1
United States of America1
Europe1

Where are Research Centers of Capsida Biotherapeutics Patents Located?

The Research Centers of Capsida Biotherapeutics Patents is the United States of America.

List of Capsida Biotherapeutics patents

Capsida Biotherapeutics PatentsTitle
US20230303630A1Adeno-Associated Virus Compositions Having Preferred Expression Levels
EP4199972A2Adeno-Associated Virus Compositions Having Preferred Expression Levels
WO2023225508A3Selected Adeno-Associated Virus Compositions Having Preferred Brain, Spinal Cord, And/Or Heart Expression Levels
WO2023244920A2Adeno-Associated Virus Compositions Having Increased Brain Enrichment And/Or Heart Enrichment
WO2023244919A1Adeno-Associated Virus Compositions Having Increased Brain Enrichment And Decreased Liver Enrichment
WO2023183582A3Selected Aav Compositions Having Preferred Brain Enrichment
WO2023215546A2Adeno-Associated Virus Compositions Having Increased Brain Enrichment
WO2023183583A3Adeno-Associated Virus Compositions Having Increased Heart Enrichment
AU2022258447A1Aav Compositions Having High Expression Levels In Brain
AU2021329527A1Adeno-Associated Virus Compositions Having Preferred Expression Levels
CA3216172A1Aav Compositions Having High Expression Levels In Brain
CA3192600A1Adeno-Associated Virus Compositions Having Preferred Expression Levels
JP2023538129AAdeno-Associated Virus Compositions With Favorable Expression Levels
WO2022221400A3Aav Compositions Having High Expression Levels In Brain
WO2022221420A3Selected Aav Compositions Having Preferred Brain Enrichment
WO2022221421A3Aav Compositions With High Brain Expression For Treating Mucopolysaccharidosis Ii
WO2022221404A3Adeno-Associated Virus Compositions Having Increased Brain Enrichment
WO2022221397A3Plasmids And Methods Of Production Of Adeno-Associated Viruses
WO2022040527A3Adeno-Associated Virus Compositions Having Preferred Expression Levels
WO2022040530A3Virus Compositions For Treating Mucopolysaccharidosis Ii

What are Capsida Biotherapeutics key innovation segments?

What Technologies are Covered by Capsida Biotherapeutics?

The chart below distributes patents filed by Capsida Biotherapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Capsida Biotherapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Capsida Biotherapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Capsida Biotherapeutics?

Related Articles

Weo Llc Patents – Insights & Stats (Updated 2024)

Weo Llc has a total of 47 patents globally, out of which 9 have been granted. Of these 47 patents, more than 87% patents are active. The United States of America is where Weo Llc has filed the maximum number of patents, followed by Brazil and Australia. Parallelly, France seems

Read More »

Fortephest Patents – Insights & Stats (Updated 2024)

Fortephest has a total of 23 patents globally. Of these 23 patents, more than 91% patents are active. Argentina is where Fortephest has filed the maximum number of patents, followed by New Zealand and Australia. Parallelly, The United States of America seems to be the main focused R&D center and

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.